Recommended Topic Related To:

Ancobon

"Oct. 28, 2012 -- Flu vaccines may do more than guard against infection. New research hints that the vaccine, which is recommended for all adults, may also help the heart.

Two new studies presented at the 2012 Canadian Cardiovascular C"...

Ancobon

Ancobon

INDICATIONS

Ancobon (flucytosine) is indicated only in the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus.

Candida: Septicemia, endocarditis and urinary system infections have been effectively treated with flucytosine. Limited trials in pulmonary infections justify the use of flucytosine.

Cryptococcus: Meningitis and pulmonary infections have been treated effectively. Studies in septicemias and urinary tract infections are limited, but good responses have been reported.

Ancobon (flucytosine) should be used in combination with amphotericin B for the treatment of systemic candidiasis and cryptococcosis because of the emergence of resistance to Ancobon (See Microbiology).

DOSAGE AND ADMINISTRATION

The usual dosage of Ancobon (flucytosine) is 50 to 150 mg/kg/day administered in divided doses at 6-hour intervals. Nausea or vomiting may be reduced or avoided if the capsules are given a few at a time over a 15-minute period. If the BUN or the serum creatinine is elevated, or if there are other signs of renal impairment, the initial dose should be at the lower level (see WARNINGS).

Ancobon (flucytosine) should be used in combination with amphotericin B for the treatment of systemic candidiasis and cryptococcosis because of the emergence of resistance to Ancobon (See Microbiology).

HOW SUPPLIED

Capsules, 250 mg (gray and green), imprinted ANCOBON® (flucytosine) 250 ICN, bottles of 100 (NDC 0187-3554-10). Capsules, 500 mg (gray and white), imprinted ANCOBON® (flucytosine) 500 ICN, bottles of 100 (NDC 0187-3555-10). Store at 25°C (77°F); excursions permitted to 15°C - 30°C (59°F - 86°F).

Valeant Pharmaceuticals International, 3300 Hyland Avenue, Costa Mesa, California 92626. 714-545-0100. Rev. May 2006. FDA Rev date: 8/10/2006

Last reviewed on RxList: 10/8/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Ancobon - User Reviews

Ancobon User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Ancobon sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Heart Health

Get the latest treatment options.

Health Resources
advertisement
advertisement
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations